Medscape is available in 5 Language Editions – Choose your Edition here.


Toe Walking Treatment & Management

  • Author: Ryan Krochak, MD; Chief Editor: Jason H Calhoun, MD, FACS  more...
Updated: Jun 20, 2014

Medical Therapy

Nonoperative treatment of toe walking includes stretching, casting, orthotics, and chemodenervation with botulinum toxin. The success of such treatment depends on the age of the patient, the severity of the equinus deformity, and the underlying etiology.

Stretching is often the first treatment attempted for toe walking because it is the least invasive. It is recognized that stretching and physical therapy offer a limited chance of success for treating idiopathic toe walking (ITW), and it is more often used in an attempt to maintain range of motion gained by other methods.[7] Stretching must use the patient's body weight, since the lower extremity muscles are too powerful to allow effective passive stretch by parents or therapists. In one technique, the child is stood with the forefoot elevated on a small block so that the heel may drop downward. The parents steady the child and add gentle pressure to the stretching process. In a second technique, the patient leans forward against a counter, with feet together and pointed straight forward, knees straight, and hips extended. Progressive stretch is accomplished by increasing the distance from the counter.

Serial casting is another nonoperative technique for stretching the Achilles tendon.[30] The child is placed in a below-the-knee plaster or fiberglass cast while the knee is flexed and foot is dorsiflexed, most easily done with the child prone and while an assistant pushes gently downward on the forefoot. Once the cast has set, the gastrocnemius component stretches further as the knee extends. These casts are changed weekly or biweekly to progressively increase the range of dorsiflexion. Between cast changes, the child can walk with the use of cast shoes.

A custom orthotic such as the articulated molded ankle-foot orthosis (AFO), as seen in the image below, is another option for nonoperative treatment. This appliance is cosmetically acceptable, fits in a regular shoe, allows nearly normal ambulation, and prevents plantarflexion while allowing full dorsiflexion with every step. An AFO in a growing child can be expected to fit for 12-18 months before requiring replacement.

An articulated molded ankle-foot orthosis (MAFO); An articulated molded ankle-foot orthosis (MAFO); this cosmetic appliance fits into a regular shoe. It allows free dorsiflexion but prevents plantarflexion and hence, toe walking.

For toe walking due to muscle spasticity, stretching alone is ineffective.[31] Serial casting can be used to lengthen the Achilles tendon, but the contracture recurs rapidly unless the patient is maintained in an AFO. An articulated molded AFO used consistently is an effective appliance for preventing the progression of spastic equinus that occurs with growth. If a patient with spasticity continues to toe walk when AFOs are discontinued after the patient reaches skeletal maturity, operative lengthening may then be considered so that the orthosis can be discontinued. After skeletal maturity, equinus in a patient who is spastic is less likely to recur.[21]

Chemodenervation of the gastrocnemius-soleus complex muscles with botulinum toxin is another method of nonoperative treatment. Botulinum toxin causes temporary (approximately 3 months) selective muscle paralysis by blocking acetylcholine release at the neuromuscular junction. It was first introduced in the early 1990s as an injection into the gastrocnemius muscle in an attempt to decrease tone in patients with cerebral palsy.[32] Subsequently, its suggested indications have expanded to ITW, but most studies have demonstrated little efficacy to this approach.[33]

For toe walking associated with paralytic muscle disease, the use of regular stretching and orthoses together should be considered while the child remains ambulatory. Both modalities of nonoperative treatment are preferable to operative lengthening, as the latter weakens the muscle and interferes with ambulation. Prolonged use of serial casts also weakens muscles and should be avoided.[22]


Surgical Therapy

If conservative measures fail to correct idiopathic toe walking (ITW) after about 12 months, operative lengthening is considered. Indications for Achilles lengthening include ankle equinus that exists both with the knee flexed as well as extended and interferes with gait. This procedure can be performed under a brief anesthetic by either an open or percutaneous technique.[13, 34]

An open heel-cord lengthening is performed through either a medial incision approximately 6-8 cm in length or a transverse incision at the level of the malleoli. A straight, longitudinal posterior incision centered over the tendon is avoided in order to decrease the risk of wound dehiscence and because the skin scar may contract and limit dorsiflexion. The tendon sheath is opened, and the tendon is incised longitudinally over the full length of the exposure, dividing the tendon into 2 equal halves. One half is detached proximally and the other half distally in a Z fashion. The two halves of the tendon are then sutured back together at the desired length. Following the procedure, the patient is immobilized in a below-the-knee cast for approximately 6 weeks.

A percutaneous rather than open lengthening of the Achilles tendon is also an option for most patients with ITW. To perform this technique, an assistant holds the patient's foot and ankle in maximum dorsiflexion after the skin is prepared. A thin-bladed tenotomy knife is inserted through a small medial stab wound 5-8 cm above the calcaneal insertion, depending on the size of the patient. By feel, the medial half of the proximal tendon is divided. A second medial stab wound just above the distal insertion is made and the anterior half of the tendon is divided. If the tendon has rotated a full 90º over this length, half of the fibers have been cut proximally and the other half have been cut distally. The assistant feels the tendon give, and the equinus contracture may then be corrected.

The amount of correction is controlled by immobilizing the foot and ankle in a below-the-knee cast in the desired position. If the tendon fails to part with 2 incisions, a third stab wound is made from straight posterior, halfway between the first 2 incisions. Through this, the lateral half of the fibers is cut until the tendon gives.

Open and percutaneous techniques are also applicable to patients with toe walking secondary to muscle spasticity. However, it is critical to determine whether a component of the toe walking is caused by spastic flexion of the knee and possibly also of the hip. Is the ankle truly in equinus or is the patient bearing weight on the forefoot because the knee is flexed? If the latter is true, heel cord lengthening results in a progressive crouch gait with worsened overall function and should therefore be avoided. Such a patient may benefit from a lengthening the hamstrings and possibly the hip flexors, not the gastrocnemius. However, management of complex spastic gait is beyond the scope of this article.

Patients with hemiplegic spasticity involving one lower extremity usually have true equinus. If the patient walks with the knee no more than slightly flexed and the ankle is in definite plantarflexion, the heel cord can safely be lengthened. If the ankle can be brought passively to neutral with the knee flexed, but falls into equinus as the knee is extended, the gastrocnemius insertion alone should be addressed. The gastrocnemius aponeurosis can be lengthened just before it joins the aponeurosis of the soleus (Vulpius or Baker) or the gastrocnemius to Achilles muscle-tendon junction can be lengthened selectively (Strayer procedure).[7] If the ankle remains in significant equinus despite knee flexion, the Achilles tendon itself is lengthened through either an open or percutaneous technique, as described.

Heel cord lengthening can be considered in a patient with paralytic muscle disease who walks on the toes, but only if the knee extends fully and the quadriceps muscle has normal or near-normal strength. If the patient is using toe walking to generate an extension moment at the knee to compensate for a weak quadriceps, lengthening the heel cord causes a premature loss of ambulation. All patients with Duchenne muscular dystrophy during their last few years of ambulation use toe walking to compensate for weak knee extensors. Management of toe walking in such patients should be limited to nonoperative modalities such as bracing.


Postoperative Details

After a heel cord is surgically lengthened, the patient is typically immobilized in a below-the-knee cast for approximately 4-6 weeks. The position of the ankle is thought to be critical if a percutaneous approach was used, as the ankle is placed into more dorsiflexion if more lengthening is desired and less dorsiflexion if less lengthening is desired.

Adequate pain control in the acute postoperative setting is imperative both to promote the child’s comfort and to reduce muscle spasms, which may alter the desired surgical correction. The limb(s) should be elevated for 2-3 days until acute swelling resolves. Weightbearing on the limb is routinely permitted if a percutaneous or open sliding tendon lengthening was performed. For patients with open Z-lengthening, some surgeons prefer non-weightbearing until tendon healing is sufficient (approximately 6 wk).



The patient may resume walking on the operated limb once the cast has been removed. A patient with idiopathic toe walking (ITW) manifests a plantarflexion weakness out of the cast and runs flatfooted. The gastrocnemius-soleus complex typically regains strength slowly over the subsequent few months, returning to normal within 1 year.[35] The patient is usually followed for 1-2 years after the surgical intervention to ensure that toe walking does not recur.

Immature patients with spasticity or paralytic muscle disease should be monitored closely after heel cord lengthening. With growth or continued muscle fibrosis, contractures are prone to recurrence. In these patients, stretching and/or orthotics are typically needed during growth to maintain foot position and prevent recurrence.

For excellent patient education resources, see eMedicineHealth's patient education article Cast Care.



The chief concern following operative heel cord lengthening for a patient with idiopathic toe walking (ITW) is recurrence. Although recurrence in ITW after surgery is uncommon, the authors have used molded ankle-foot orthoses (AFOs) for up to a year to manage recurrence before considering repeat operative lengthening. The diagnostic workup should be revisited for any patient with recurrent ITW after surgery as a means of looking for signs of neuromuscular disease or intraspinal pathology that might not have initially been evident.

Recurrence following operative heel cord lengthening is common in neuromuscular diseases, owing to continued spasticity and extremity growth. The appropriate use of an orthosis and stretching can help prevent this complication. A feared postoperative complication for patients with toe walking secondary to spasticity or paralytic muscle disease is deterioration of independent ambulation. Such complications are minimized by a careful preoperative evaluation and judicious selection as well as execution of a heel cord procedure. If function is adversely impacted by tendon lengthening, the foot and ankle should be supported with an orthosis.

Lastly, wound dehiscence, necrosis, and cutaneous nerve injury are relatively rare complications.


Outcome and Prognosis

The long-term results of treatment for idiopathic toe walking (ITW) is unclear as most studies mix a variety of management methods, making it difficult to critically evaluate individual treatment options.

Stretching casts have a variable reported outcome. In a long-term study of 14 children with ITW treated with a stretching regimen with or without casting, only 3 children required additional treatment for persistent toe walking after several years.[36] However, in a larger series of patients, no difference was seen in outcome between patients treated with observation or serial casting, with 50% of both groups showing improvement in gait.[20] Other authors have demonstrated similar variability, with one study showing that 66% of patients have improved ankle dorsiflexion and gait following casting.[20, 30, 37] Casting management overall seems to be most successful in patients with an initial ankle dorsiflexion of greater than 0º. In addition, recurrence of toe walking is unlikely in patients who have spontaneously discontinued toe walking or who remain down on their heels for more than 1 year following casting treatment.[4]

Surgical management of ITW, either through isolated gastrocnemius lengthening or Achilles lengthening, appears to be effective when used in the appropriate clinical setting.[34] In one study, 72% of surgically treated patients reported a normal or improved gait at follow up.[20] Another study noted all patients treated surgically showed an improvement in ankle dorsiflexion and parental satisfaction was reported to be 67%.[37] In long-term outcome studies, surgical management seems to be more effective than nonsurgical management. However, direct comparison is difficult, owing to the variability in patient age and disease severity in these studies.[20]

The prognosis for patients with spasticity or paralytic muscle disease is less predictable. These patients require long-term follow-up, as recurrence rates are high.[38] For ambulatory cerebral palsy patients without a fixed ankle contracture, treatment with full-time bracing (ankle-foot orthoses [AFOs]) has been shown to have a positive effect on ankle range of motion and power at push-off.[31]

For cerebral palsy patients with a rigid deformity, data indicate that children younger than 7 years at the time of surgery have a higher risk of recurrence. Hemiplegic patients have also been found to have higher recurrence rates compared with diplegic cerebral palsy patients.[39] In one long-term study, surgical lengthening in cerebral palsy patients with a fixed equinus contracture resulted in a significant gain in dorsiflexion from a preoperative average of -25° to 8° of dorsiflexion postoperatively, and this correction was shown to be maintained by stretching and AFOs in 80% of patients 7 years after the index procedure.[40]

Botulinum toxin alone has not been shown in randomized control trials to offer improved outcomes over the long term when compared with casting alone for dynamic equinus in children with cerebral palsy or ITW.[33, 41] Furthermore, combining botulinum toxin injections with casting does not improve the results for either patients cerebral palsy CP or ITW compared with casting alone.[33, 41]


Future and Controversies

Some controversies exist regarding the widespread use of electromyography (EMG) and gait analysis in diagnosis. However, both analyses may be helpful in select patients. (see Other Tests).

An auditory feedback system to assist in gait rehabilitation of cerebral palsy patients with dynamic toe walking has recently been developed. Based on plantar pressure monitors embedded in shoes, this system can monitor toe-walking strides in real time and produce an auditory signal to alert patients when toe walking has been detected. Although this system was designed to identify toe-walking strides in children with cerebral palsy, its use may also be expanded in the future to provide a behavior-modifying feedback system for children with idiopathic toe walking (ITW).[42]

Contributor Information and Disclosures

Ryan Krochak, MD Resident Physician, Department of Orthopedic Surgery, Maimonides Medical Center

Ryan Krochak, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Medical Association, Brooklyn Orthopaedic Society

Disclosure: Nothing to disclose.


Mark C Lee, MD Assistant Professor, Department of Orthopedics, Connecticut Children’s Medical Center

Mark C Lee, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, Connecticut State Medical Society, Scoliosis Research Society, Pediatric Orthopaedic Society of North America, Connecticut Orthopaedic Society

Disclosure: Received honoraria from Synthes-Depuy for speaking and teaching.

Specialty Editor Board

Francisco Talavera, PharmD, PhD Adjunct Assistant Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Received salary from Medscape for employment. for: Medscape.

Chief Editor

Jason H Calhoun, MD, FACS Department Chief, Musculoskeletal Sciences, Spectrum Health Medical Group

Jason H Calhoun, MD, FACS is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American College of Surgeons, American Diabetes Association, American Medical Association, American Orthopaedic Association, American Orthopaedic Foot and Ankle Society, Michigan State Medical Society, Missouri State Medical Association, Southern Medical Association, Southern Orthopaedic Association, Texas Medical Association, Texas Orthopaedic Association, Musculoskeletal Infection Society

Disclosure: Nothing to disclose.

Additional Contributors

John S Early, MD Foot/Ankle Specialist, Texas Orthopaedic Associates, LLP; Co-Director, North Texas Foot and Ankle Fellowship, Baylor University Medical Center

John S Early, MD is a member of the following medical societies: American Academy of Orthopaedic Surgeons, American Medical Association, American Orthopaedic Foot and Ankle Society, Orthopaedic Trauma Association, Texas Medical Association

Disclosure: Received honoraria from AO North America for speaking and teaching; Received consulting fee from Stryker for consulting; Received consulting fee from Biomet for consulting; Received grant/research funds from AO North America for fellowship funding; Received honoraria from MMI inc for speaking and teaching; Received consulting fee from Osteomed for consulting; Received ownership interest from MedHab Inc for management position.


Edwards P Schwentker, MD Professor, Departments of Orthopedics and Rehabilitation and Pediatrics, Pennsylvania State College of Medicine

Disclosure: Nothing to disclose.

  1. Dobbs MB, Morcuende JA, Gurnett CA, Ponseti IV. Treatment of idiopathic clubfoot: an historical review. Iowa Orthop J. 2000. 20:59-64. [Medline]. [Full Text].

  2. Caselli MA, Rzonca EC, Lue BY. Habitual toe-walking: evaluation and approach to treatment. Clin Podiatr Med Surg. 1988 Jul. 5(3):547-59. [Medline].

  3. Sutherland DH, Olshen R, Cooper L, Woo SL. The development of mature gait. J Bone Joint Surg Am. 1980 Apr. 62(3):336-53. [Medline].

  4. Pernet J, Billiaux A, Auvin S, Rakatovao D, Morin L, Presedo A. Early onset toe-walking in toddlers: a cause for concern?. J Pediatr. 2010 Sep. 157(3):496-8. [Medline].

  5. Engelbert R, Gorter JW, Uiterwaal C, van de Putte E, Helders P. Idiopathic toe-walking in children, adolescents and young adults: a matter of local or generalised stiffness?. BMC Musculoskelet Disord. 2011 Mar 21. 12:61. [Medline]. [Full Text].

  6. Engström P, Tedroff K. The prevalence and course of idiopathic toe-walking in 5-year-old children. Pediatrics. 2012 Aug. 130(2):279-84. [Medline].

  7. Oetgen ME, Peden S. Idiopathic toe walking. J Am Acad Orthop Surg. 2012 May. 20(5):292-300. [Medline].

  8. Barrow WJ, Jaworski M, Accardo PJ. Persistent toe walking in autism. J Child Neurol. 2011 May. 26(5):619-21. [Medline].

  9. Engström P, Van't Hooft I, Tedroff K. Neuropsychiatric symptoms and problems among children with idiopathic toe-walking. J Pediatr Orthop. 2012 Dec. 32(8):848-52. [Medline].

  10. Oskoui M, Coutinho F, Dykeman J, Jetté N, Pringsheim T. An update on the prevalence of cerebral palsy: a systematic review and meta-analysis. Dev Med Child Neurol. 2013 Jun. 55(6):509-19. [Medline].

  11. Rodino-Klapac LR, Mendell JR, Sahenk Z. Update on the treatment of Duchenne muscular dystrophy. Curr Neurol Neurosci Rep. 2013 Mar. 13(3):332. [Medline].

  12. McAbee GN. Acute toe walking with viral myositis. Pediatr Neurol. 2013 Nov. 49(5):e11. [Medline].

  13. Hall JE, Salter RB, Bhalla SK. Congenital short tendo calcaneus. J Bone Joint Surg Br. 1967 Nov. 49(4):695-7. [Medline].

  14. Williams CM, Tinley P, Curtin M, Wakefield S, Nielsen S. Is idiopathic toe walking really idiopathic? The motor skills and sensory processing abilities associated with idiopathic toe walking gait. J Child Neurol. 2014 Jan. 29(1):71-8. [Medline].

  15. Sobel E, Caselli MA, Velez Z. Effect of persistent toe walking on ankle equinus. Analysis of 60 idiopathic toe walkers. J Am Podiatr Med Assoc. 1997 Jan. 87(1):17-22. [Medline].

  16. Neptune RR, Burnfield JM, Mulroy SJ. The neuromuscular demands of toe walking: a forward dynamics simulation analysis. J Biomech. 2007. 40(6):1293-300. [Medline].

  17. Sasaki K, Neptune RR, Burnfield JM, Mulroy SJ. Muscle compensatory mechanisms during able-bodied toe walking. Gait Posture. 2008 Apr. 27(3):440-6. [Medline].

  18. Westberry DE, Davids JR, Davis RB, de Morais Filho MC. Idiopathic toe walking: a kinematic and kinetic profile. J Pediatr Orthop. 2008 Apr-May. 28(3):352-8. [Medline].

  19. Solan MC, Kohls-Gatzoulis J, Stephens MM. Idiopathic toe walking and contractures of the triceps surae. Foot Ankle Clin. 2010 Jun. 15(2):297-307. [Medline].

  20. Eastwood DM, Menelaus MB, Dickens DR, Broughton NS, Cole WG. Idiopathic toe-walking: does treatment alter the natural history?. J Pediatr Orthop B. 2000 Jan. 9(1):47-9. [Medline].

  21. Green NE. The orthopaedic management of the ankle, foot, and knee in patients with cerebral palsy. Instr Course Lect. 1987. 36:253-65. [Medline].

  22. Williams EA, Read L, Ellis A, Morris P, Galasko CS. The management of equinus deformity in Duchenne muscular dystrophy. J Bone Joint Surg Br. 1984 Aug. 66(4):546-50. [Medline].

  23. Doral MN, Alam M, Bozkurt M, Turhan E, Atay OA, Dönmez G, et al. Functional anatomy of the Achilles tendon. Knee Surg Sports Traumatol Arthrosc. 2010 May. 18(5):638-43. [Medline].

  24. Hicks R, Durinick N, Gage JR. Differentiation of idiopathic toe-walking and cerebral palsy. J Pediatr Orthop. 1988 Mar-Apr. 8(2):160-3. [Medline].

  25. Kelly IP, Jenkinson A, Stephens M, O'Brien T. The kinematic patterns of toe-walkers. J Pediatr Orthop. 1997 Jul-Aug. 17(4):478-80. [Medline].

  26. Williams CM, Tinley P, Curtin M. The Toe Walking Tool: a novel method for assessing idiopathic toe walking children. Gait Posture. 2010 Oct. 32(4):508-11. [Medline].

  27. Kalen V, Adler N, Bleck EE. Electromyography of idiopathic toe walking. J Pediatr Orthop. 1986 Jan-Feb. 6(1):31-3. [Medline].

  28. Policy JF, Torburn L, Rinsky LA, Rose J. Electromyographic test to differentiate mild diplegic cerebral palsy and idiopathic toe-walking. J Pediatr Orthop. 2001 Nov-Dec. 21(6):784-9. [Medline].

  29. Rose J, Martin JG, Torburn L, Rinsky LA, Gamble JG. Electromyographic differentiation of diplegic cerebral palsy from idiopathic toe walking: involuntary coactivation of the quadriceps and gastrocnemius. J Pediatr Orthop. 1999 Sep-Oct. 19(5):677-82. [Medline].

  30. Fox A, Deakin S, Pettigrew G, Paton R. Serial casting in the treatment of idiopathic toe-walkers and review of the literature. Acta Orthop Belg. 2006 Dec. 72(6):722-30. [Medline].

  31. Kranzl A, Grasl C, Csepan R, Grill F. Outcome of 23h Bracing for Tip-toe-walking Children with Cerebral Palsy. Biomed Tech (Berl). 2013 Sep 7. [Medline].

  32. Koman LA, Mooney JF 3rd, Smith B, Goodman A, Mulvaney T. Management of cerebral palsy with botulinum-A toxin: preliminary investigation. J Pediatr Orthop. 1993 Jul-Aug. 13(4):489-95. [Medline].

  33. Engström P, Bartonek Å, Tedroff K, Orefelt C, Haglund-Åkerlind Y, Gutierrez-Farewik EM. Botulinum toxin A does not improve the results of cast treatment for idiopathic toe-walking: a randomized controlled trial. J Bone Joint Surg Am. 2013 Mar 6. 95(5):400-7. [Medline].

  34. McMulkin ML, Baird GO, Caskey PM, Ferguson RL. Comprehensive outcomes of surgically treated idiopathic toe walkers. J Pediatr Orthop. 2006 Sep-Oct. 26(5):606-11. [Medline].

  35. Hemo Y, Macdessi SJ, Pierce RA, Aiona MD, Sussman MD. Outcome of patients after Achilles tendon lengthening for treatment of idiopathic toe walking. J Pediatr Orthop. 2006 May-Jun. 26(3):336-40. [Medline].

  36. Hirsch G, Wagner B. The natural history of idiopathic toe-walking: a long-term follow-up of fourteen conservatively treated children. Acta Paediatr. 2004 Feb. 93(2):196-9. [Medline].

  37. Stricker SJ, Angulo JC. Idiopathic toe walking: a comparison of treatment methods. J Pediatr Orthop. 1998 May-Jun. 18(3):289-93. [Medline].

  38. Rattey TE, Leahey L, Hyndman J, Brown DC, Gross M. Recurrence after Achilles tendon lengthening in cerebral palsy. J Pediatr Orthop. 1993 Mar-Apr. 13(2):184-7. [Medline].

  39. Koman LA, Smith BP, Barron R. Recurrence of equinus foot deformity in cerebral palsy patients following surgery: a review. J South Orthop Assoc. 2003. 12(3):125-33, quiz 134. [Medline].

  40. Damron TA, Greenwald TA, Breed AL. Chronologic outcome of surgical tendoachilles lengthening and natural history of gastroc-soleus contracture in cerebral palsy. A two-part study. Clin Orthop Relat Res. 1994 Apr. (301):249-55. [Medline].

  41. Ackman JD, Russman BS, Thomas SS, Buckon CE, Sussman MD, Masso P. Comparing botulinum toxin A with casting for treatment of dynamic equinus in children with cerebral palsy. Dev Med Child Neurol. 2005 Sep. 47(9):620-7. [Medline].

  42. Pu F, Fan X, Yang Y, Chen W, Li S, Li D. Feedback system based on plantar pressure for monitoring toe-walking strides in children with cerebral palsy. Am J Phys Med Rehabil. 2014 Feb. 93(2):122-9. [Medline].

An articulated molded ankle-foot orthosis (MAFO); this cosmetic appliance fits into a regular shoe. It allows free dorsiflexion but prevents plantarflexion and hence, toe walking.
All material on this website is protected by copyright, Copyright © 1994-2016 by WebMD LLC. This website also contains material copyrighted by 3rd parties.